Presence of GABAB Receptors Forming Heterodimers With GABAB1 and GABAB2 Subunits in Human Lower Esophageal Sphincter

Abstract

Baclofen, a GABAB-receptor (GABABR) agonist has been proposed to be useful as therapeutic agent for the management of gastro-esophageal reflux disease, but whether the compound acts directly at the lower esophageal sphincter (LES) remains to be elucidated. We performed the present study to assess the presence of GABABR in human LES. Western blot analysis showed that both proteins of GABAB1(a)/GABAB1(b) and GABAB2 subunits were present in the muscle layer of LES. Immunohistochemical findings showed that both GABAB1- and GABAB2-subunit proteins were located on the neurons within the myenteric plexus, and furthermore, both proteins were observed in the same neurons. Reverse transcriptase-polymerase chain reaction analysis also revealed the presence of mRNAs for both subunits of GABABR and also mRNAs for 6 isoforms of GABAB1 subunits, from GABAB1(a) to GABAB1(g), except GABAB1(d), in human LES. Thus, the functional GABABR-forming heterodimers with subunits of GABAB1 and GABAB2 are located on the myenteric neurons in human LES, suggesting that GABABR agonists and antagonists act at least, at the level of the peripheral nervous system.